Drug Utilization Review Board
Meeting Agenda
Thursday, September 12, 2024
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/izx-upgq-ari
Or dial: (US) +1 570-671-0097 PIN: 796 670 400 #
Persons who wish to address the DUR Board may contact Ngan Huynh at (nganhuynh@utah.gov) prior to the meeting or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Eric Cannon, PharmD
a) Announce Quorum
2) Welcome and Introductions - Eric Cannon, PharmD
a) Review and Approval of Minutes
b) Housekeeping
3) Review
a) High-Dose Therapy and Multiple Antipsychotics in Adults: Guideline Summary and Retrospective Utilization Review - University of Utah DRRC
i) Public Comment
(1) Teva Pharmaceuticals - Mandeep Sohal, PharmD
(2) Abbvie - Vraylar (cariprazine) - Bradley Jones, MD
ii) Committee Discussion/Questions
b) Rezdiffra (resmetirom) Prior Authorization - Ngan Huynh, PharmD
i) Committee Discussion/Questions
c) Berinert, Firazyr, Kalbitor, Ruconest Prior Authorization - Ngan Huynh, PharmD
i) Committee Discussion/Questions
4) Next Meeting
a) October 10, 2024 - Antipsychotics used in Adults (Cont)
5) Adjourned
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Ngan Huynh at 801-538-6014.
Notice of Electronic or Telephone Participation
Google Meet joining info
Video call link: meet.google.com/izx-upgq-ari
Or dial: (US) +1 570-671-0097 PIN: 796 670 400 #